Di Costanzo, Francesco <br/><br/>
Capecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes' C colon cancer : economic evaluation in an Italian NHS setting.  [electronic resource] 

 -  Clinical drug investigation  2008 
 - 645-55 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1173-2563 
<br/><br/><label>Standard No.: </label>10.2165/00044011-200828100-00005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Capecitabine<br/>Chemotherapy, Adjuvant--economics<br/>Clinical Trials, Phase III as Topic--economics<br/>Colonic Neoplasms--drug therapy<br/>Cost-Benefit Analysis<br/>Deoxycytidine--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Health Care Costs<br/>Humans<br/>Infusions, Parenteral--economics<br/>Italy<br/>Leucovorin--administration & dosage<br/>Male<br/>Middle Aged<br/>National Health Programs--economics<br/>Randomized Controlled Trials as Topic--economics<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult